ETFIQData as of Nov 19, 2026. · etfiq.com/funds/ihiDownload PDF

IHI Fact Sheet: iShares U.S. Medical Devices ETF

Share
$55.38
close, Nov 20, 2026

Over the year to Nov 19, 2026, IHI returned −9.1% in total and charged 0.37% a year.

1-year total return
−9.0%
to Nov 20, 2026
Expense ratio
0.37%
a year
Net assets
$3.9bn
on Nov 19, 2026
Net flow, last 4 trading days
−$11.5m
daily basis to Nov 18, 2026

Growth of $10,000, 1 year

IHI $9,093 −9.1% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month+3.7%
3 months−1.3%
Year to date−10.6%
1 year−9.0%
3 years+13.0%
5 years−12.4%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
ABBOTT LABORATORIES17.17%
INTUITIVE SURGICAL13.75%
MEDTRONIC PLC11.77%
IDEXX LABORATORIES5.56%
EDWARDS LIFESCIENCES5.00%
BECTON DICKINSON & COMPANY4.91%
GE HEALTHCARE TECHNOLOGIES4.76%
STRYKER4.72%
RESMED4.40%
BOSTON SCIENTIFIC3.97%

IHI top ten by weight, 76.0% of the fund, of its 51 equity positions, from the holdings published by its issuer for Nov 19, 2026.

Facts

Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies · First traded May 5, 2006 · Benchmark Its own holdings, as of Nov 19, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, IHI Fact Sheet: iShares U.S. Medical Devices ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/ihi/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/ihi.